• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

iCAD third quarter revenues drop

Article

Third quarter revenues at computer-aided detection specialist iCAD dropped 37% to $7.1 million, but the company stayed in the black with net income of $113,000 compared with net income of $2.1 million in the year earlier period.

iCAD third quarter revenues drop
Third quarter revenues at computer-aided detection specialist iCAD dropped 37% to $7.1 million, but the company stayed in the black with net income of $113,000 compared with net income of $2.1 million in the year earlier period.  For the first nine months total revenue declined 29% to $20.0 million from $28.2 million. Sales of digital CAD and MRI products led the decline with revenues falling to $12.7 million compared with $20.4 million over the two nine-month periods. Service and supply revenues actually increased to $2.8 million compared with $2.5 million. Film-based revenue of $4.6 million fell from $5.3 million. The company’s core digital mammography CAD business showed increased demand in the third quarter versus the second quarter, according to the company, as evidenced by the increased placements of full-field digital mammography systems posted in the Mammography Quality Standards Act data on the FDA website. Overall, revenues grew 24% compared with the second quarter of 2009. Ken Ferry, iCAD president and CEO, said he expects the sequential revenue growth to continue into the fourth quarter.
 

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.